Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

diabetes mellitus/proline

Veza se sprema u međuspremnik
13 rezultatima
FIELD OF THE INVENTION The present invention is directed to L-proline and citric acid co-crystals of (2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylp- henyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, pharmaceutical compositions containing said co-crystals and their

D-proline derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION 1. Field The invention relates to D-prolines and their use in treating diseases associated with amyloidosis. 2. Description The compounds (R)-1-[(R)- -3-mercapto-2-methyl-propionyl]-pyrrolidine-2-carboxylic acid and

D-proline derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION 1. Field The invention relates to D-prolines and their use in treating diseases associated with amyloidosis. 2. Description The compounds (R)-1-[(R)-3-mercapto-2-methyl-propionyl]-pyrrolidine-2-carboxylic acid and

D-proline derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION 1. Field The invention relates to D-prolines and their use in treating diseases associated with amyloidosis. 2. Description The compounds (R)-1-[(R)-3-mercapto-2-methyl-propionyl]-pyrrolidine-2-carboxylic acid and

D-proline derivatives

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
BACKGROUND OF THE INVENTION 1. Field The invention relates to D-prolines and their use in treating diseases associated with amyloidosis. 2. Description The compounds (R)-1-[(R)- -3-mercapto-2-methyl-propionyl]-pyrrolidine-2-carboxylic acid and

Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to the novel compound (2R,2'R)-Bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders

Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
This application is a .sctn.371 of International Application No. PCT/EP2015/058998, filed 27 Apr. 2015, which claims priority of GB 1407506.3, filed 29 Apr. 2014. FIELD OF THE INVENTION The present invention relates to the novel compound

Prodrug of 1,1'-(1,6-dioxo -1,6-hexanediyl)bis-D-proline

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to the novel compound (2R,2'R)-Bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders

Prodrug of 1,1'-(1,6-dioxo-1,6-hexanediyl)bis-D-proline

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to the novel compound (2R,2'R)-Bis(((((tetrahydro-2H-pyran-4-yl)oxy)carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders

D-proline derivatives as SAP depleting agent

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to the compound (2R,2'R)-bis(((tetrahydro-2H-pyran-4-carbonyl)oxy)methyl) 1,1'-adipoylbis(pyrrolidine-2-carboxylate), pharmaceutical compositions comprising the same and the use of the same for treatment of diseases or disorders wherein depletion

Ertugliflozin co-crystals and process for their preparation

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to processes for the preparation of an ertugliflozin-L-pyroglutamic acid (1:1) co-crystal and ertugliflozin-L-proline (1:1) co-crystal. The present invention further relates to an ertugliflozin-L-proline (1:2) co-crystal, processes for its

Multivalent inhibitors of serum amyloid P component

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
FIELD OF THE INVENTION The present invention relates to new glycerol cyclic pyruvate derivatives and their use, in particular in the treatment or prevention of amyloidosis. BACKGROUND OF THE INVENTION Human serum amyloid P component (SAP) is a normal plasma protein that has been associated with

Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use

Samo registrirani korisnici mogu prevoditi članke
Prijava Registriraj se
The present invention relates to a protein hydrolysate enriched in certain peptides, such isolated peptides, and the use of such protein hydrolysate or isolated peptide for the manufacture of a medicament, food supplement, beverage or food product for prophylaxis and/or treatment of a DPP-IV
Pridružite se našoj
facebook stranici

Najkompletnija baza ljekovitog bilja potpomognuta znanošću

  • Radi na 55 jezika
  • Biljni lijekovi potpomognuti znanošću
  • Prepoznavanje bilja slikom
  • Interaktivna GPS karta - označite bilje na mjestu (uskoro)
  • Pročitajte znanstvene publikacije povezane s vašom pretragom
  • Pretražite ljekovito bilje po učincima
  • Organizirajte svoje interese i budite u toku s istraživanjem vijesti, kliničkim ispitivanjima i patentima

Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Svi podaci temelje se na objavljenim znanstvenim istraživanjima

Google Play badgeApp Store badge